Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
出版年份 2017 全文链接
标题
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
作者
关键词
Inflammatory breast cancer, Syndecan-1, Proteoglycan, Cancer stem cell, IL-6/STAT3, Notch, EGFR
出版物
Molecular Cancer
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-03-07
DOI
10.1186/s12943-017-0621-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
- (2016) Komal Jhaveri et al. Clinical Breast Cancer
- Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway
- (2016) Eslam A. Elghonaimy et al. TUMOR BIOLOGY
- Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression
- (2016) Ivette J. Suárez-Arroyo et al. Journal of Cancer
- IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
- (2015) M. van der Zee et al. CANCER RESEARCH
- Proteoglycans as potential microenvironmental biomarkers for colon cancer
- (2015) Anastasia V. Suhovskih et al. CELL AND TISSUE RESEARCH
- A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation
- (2015) Tobias Pasqualon et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency
- (2015) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases
- (2015) Su Young Kim et al. International Journal of Medical Sciences
- The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages
- (2015) Sarah T. Boyle et al. Molecular Cancer
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
- (2015) Hyunsook An et al. PLoS One
- Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
- (2014) X Wang et al. BRITISH JOURNAL OF CANCER
- Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma
- (2014) Zhousan Zheng et al. MEDICAL ONCOLOGY
- Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
- (2014) Sherif A. Ibrahim et al. PLoS One
- Syndecans as Modulators and Potential Pharmacological Targets in Cancer Progression
- (2014) Despoina Barbouri et al. Frontiers in Oncology
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation
- (2013) Hebatallah Hassan et al. FEBS Journal
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcriptome and Coexpression Network Analysis of the Human Glioma Cell Line Hs683 Exposed to Candoxin
- (2013) Yx Jiang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells
- (2013) Keiji Shimada et al. JOURNAL OF PATHOLOGY
- Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma
- (2012) S. Blotta et al. BLOOD
- Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
- (2012) Bisrat G. Debeb et al. BREAST CANCER RESEARCH AND TREATMENT
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism
- (2012) Sherif A. Ibrahim et al. INTERNATIONAL JOURNAL OF CANCER
- Reciprocal Regulation of Syndecan-2 and Notch Signaling in Vascular Smooth Muscle Cells
- (2012) Ning Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- DDX5 Regulates DNA Replication and Is Required for Cell Proliferation in a Subset of Breast Cancer Cells
- (2012) Anthony Mazurek et al. Cancer Discovery
- Gli Proteins in Development and Disease
- (2011) Chi-chung Hui et al. Annual Review of Cell and Developmental Biology
- Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients
- (2011) Nabila Chaher et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
- (2011) Nilay Sethi et al. CANCER CELL
- HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis
- (2011) Z. C. Hartman et al. CANCER RESEARCH
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- CCL20 Stimulates Proinflammatory Mediator Synthesis in Human Fibroblast-like Synoviocytes Through a MAP Kinase-dependent Process with Transcriptional and Posttranscriptional Control
- (2011) N. ALAAEDDINE et al. JOURNAL OF RHEUMATOLOGY
- Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
- (2011) J. Li et al. ONCOLOGIST
- Inflammatory Breast Cancer: The Disease, the Biology, the Treatment
- (2010) Fredika M. Robertson et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeted therapy in inflammatory breast cancer
- (2010) Hideko Yamauchi et al. CANCER
- Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early
- (2010) Shaheenah Dawood et al. CANCER
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns
- (2010) Dunja M Baston-Büst et al. Reproductive Biology and Endocrinology
- Endometrial Cells Get Side-Tracked
- (2009) Martin Götte AMERICAN JOURNAL OF PATHOLOGY
- High Proportion of Inflammatory Breast Cancer in the Population-Based Cancer Registry of Gharbiah, Egypt
- (2009) Amr S. Soliman et al. Breast Journal
- Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells
- (2009) Jianjian Dai et al. CANCER INVESTIGATION
- Notch Activation Induces Akt Signaling via an Autocrine Loop to Prevent Apoptosis in Breast Epithelial Cells
- (2009) O. Meurette et al. CANCER RESEARCH
- Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
- (2009) Viktoriya Nikolova et al. CARCINOGENESIS
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
- (2009) B. K. Masouleh et al. JOURNAL OF IMMUNOLOGY
- The Lymphovascular Embolus of Inflammatory Breast Cancer Expresses a Stem Cell-Like Phenotype
- (2008) Yi Xiao et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
- (2008) D Loussouarn et al. BRITISH JOURNAL OF CANCER
- Defining the Clinical Diagnosis of Inflammatory Breast Cancer
- (2008) S. Eva Singletary et al. SEMINARS IN ONCOLOGY
- Inflammatory Breast Cancer in Tunisia: Reassessment of Incidence and Clinicopathological Features
- (2008) Hamouda Boussen et al. SEMINARS IN ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started